Founded in 1999, PELVIPHARM is a spin-off from the University of Versailles-Saint-Quentin-en-Yvelines (France) relying on multi-disciplinary talents (medical doctor, pharmaco-economist, veterinarian, pharmacists and PhDs) who deliver both high quality academic standards and reliable contract research services :
- Preclinical studies based on validated efficacy models including delivery of protocol development, study conduct, report, communication and peer-reviewed publication
- Guidance for selection of new chemical entities including testing with targeted assays according to potential mechanisms of action
- Identification of new properties or attributes supporting differentiation of medications within the class or between classes
- Advice in clinical development for new therapeutic indications or enhancements to address unmet medical need or significant commercial opportunities
PELVIPHARM has leading scientific and medical capabilities from unique expertise and experience in pathophysiology, pharmacology, clinical research and medical practice across a range of therapeutic areas including urology (BPH, OAB, NDO, SCI, SUI, IC …), sexual medicine (ED, PE, FSD …) and cardiovascular (Hypertension, Atherosclerosis, Myocardial Infarction …), metabolism and eating disorders (Metabolic Syndrome, Obesity, Diabetes ...)
PELVIPHARM can give you the unique expertise and the experience of a team gathered over the years.
News and next meetings
Pelvipharm at the INA (International Neurotoxin Association) in Lisbon, Portugal, 14-17 January 2015......
Season's Greetings from the team at PELVIPHARM
We wish for you the very best for the New Year and extend our sincerest gratitude for your interest ......
Future presentations at the ESSM 2015
Delphine Behr-Roussel will present the results of our ongoing studies on "Low-Intensity extracorpore......
Latest website updates
New abstract/poster available for download
presented at the EAU 2013 in Milan, Italy, 15-19 march, 2013
New experimental skills developed
New model developped